418 related articles for article (PubMed ID: 26659001)
1. microRNA and Lung Cancer.
Del Vescovo V; Denti MA
Adv Exp Med Biol; 2015; 889():153-77. PubMed ID: 26659001
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of microrna for lung cancer.
Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
6. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
9. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
[TBL] [Abstract][Full Text] [Related]
10. The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy.
Naeli P; Yousefi F; Ghasemi Y; Savardashtaki A; Mirzaei H
Curr Mol Med; 2020; 20(2):90-101. PubMed ID: 31573883
[TBL] [Abstract][Full Text] [Related]
11. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer.
Kruglyak KM; Lin E; Ong FS
Adv Exp Med Biol; 2016; 890():123-36. PubMed ID: 26703802
[TBL] [Abstract][Full Text] [Related]
14. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Therapeutic Implications of microRNAs in Non-Small Cell Lung Cancer.
Ahn YH; Ko YH
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233641
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients.
Abu-Duhier FM; Javid J; Sughayer MA; Mir R; Albalawi T; Alauddin MS
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2607-2611. PubMed ID: 30256067
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Boeri M; Pastorino U; Sozzi G
Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364
[TBL] [Abstract][Full Text] [Related]
19. Dynamic changes in circulating miRNA levels in response to antitumor therapy of lung cancer.
Ponomaryova AA; Morozkin ES; Rykova EY; Zaporozhchenko IA; Skvortsova TE; Dobrodeev АY; Zavyalov AA; Tuzikov SA; Vlassov VV; Cherdyntseva NV; Laktionov PP; Choinzonov EL
Exp Lung Res; 2016; 42(2):95-102. PubMed ID: 26986825
[TBL] [Abstract][Full Text] [Related]
20. An update on sputum MicroRNAs in lung cancer diagnosis.
Sheervalilou R; Ansarin K; Fekri Aval S; Shirvaliloo S; Pilehvar-Soltanahmadi Y; Mohammadian M; Zarghami N
Diagn Cytopathol; 2016 May; 44(5):442-9. PubMed ID: 26865409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
